Case group | OR (95 % CI) (N case/N controls) | ||
---|---|---|---|
XRCC1Arg399Gln | XRCC1Arg280His | ||
Carcinomas | GG | GA | |
GG | 1.0a (56/137) | 1.93 (0.44–8.49) (7/11) | |
GA | 0.76 (0.41–1.38) (65/180) | 1.18 (0.20–7.02) (5/7) | |
AA | 0.96 (0.44–2.09) (24/64) | - | |
Adenomas | GG | GA | |
GG | 1.0a (341/137) | 1.75 (0.85–3.63) (50/11) | |
GA | 0.85 (0.64–1.13) (415/180) | 1.22 (0.50–3.00) (27/7) | |
AA | 0.93 (0.44–1.36) (149/64) | - | |
High-risk adenomas | GG | GA | |
GG | 1.0a (83/137) | 2.92 (1.20–7.10) (17/11) | |
GA | 0.77 (0.51–1.15) (92/180) | 0.63 (0.14–2.71) (3/7) | |
AA | 0.74 (0.42–1.29) (32/64) | - | |
Low-risk adenomas | GG | GA | |
GG | 1.0a (258/137) | 1.43 (0.66–3.09) (33/11) | |
GA | 0.88 (0.65–1.18) (324/180) | 1.47 (0.59–3.66) (24/7) | |
AA | 1.00 (0.67–1.48) (117/64) |